SCHEMBL9302615

SCHEMBL9302615

OC(O)c1ccccc1OCc1ccccc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 0.53
MAPK1 P28482 1/20 0.53
TDP1 Q9NUW8 1/20 0.53
L3MBTL1 Q9Y468 1/20 0.53
LIPE Q05469 1/20 0.53
SGMS2 Q8NHU3 11/20 0.53
ALDH1A1 P00352 3/20 0.53
LMNA P02545 3/20 0.53
HTR1A P08908 2/20 0.50
ALPG P10696 1/20 0.50
PTK2B Q14289 1/20 0.50
DRD2 P14416 1/20 0.50
LTA4H P09960 1/20 0.47
MAPK14 Q16539 1/20 0.47
CYP1A2 P05177 2/20 0.47
CYP2C19 P33261 2/20 0.47
KDM4E B2RXH2 1/20 0.47
CYP2C9 P11712 1/20 0.47
ADRA1D P25100 1/20 0.46
ADRA1A P35348 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11603988 0.90 MAPT (0.55) MAPTMAPK1TDP1L3MBTL1LIPE
SCHEMBL22416666 0.86 MAPT (0.51) MAPTMAPK1TDP1L3MBTL1LIPE
SCHEMBL22416706 0.86 MAPT (0.51) MAPTMAPK1TDP1L3MBTL1LIPE
SCHEMBL3458384 0.85 TDP1 (0.55) MAPTMAPK1TDP1L3MBTL1LIPE
SCHEMBL28888783 0.85 LIPE (0.54) MAPTMAPK1TDP1L3MBTL1LIPE
SCHEMBL27810149 0.85 LIPE (0.54) MAPTMAPK1TDP1L3MBTL1LIPE
SCHEMBL477534 0.84 DRD2 (0.55) MAPTMAPK1TDP1L3MBTL1LIPE
SCHEMBL16797593 0.84 SGMS2 (0.49) MAPTMAPK1TDP1L3MBTL1LIPE
SCHEMBL11601212 0.84 SGMS2 (0.49) MAPTMAPK1TDP1L3MBTL1LIPE
SCHEMBL16797699 0.84 SGMS2 (0.49) MAPTMAPK1TDP1L3MBTL1LIPE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5310750-A Heterocyclic compounds useful as α2 -adrenoceptor antagonists BEECHAM GROUP P.L.C. (GB) 1994-05-10 US disclosed
EP-0313288-B1 IMIDAZOLE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THEIR USE AS ALPHA 2-ADRENO-RECEPTOR ANTAGONISTS BEECHAM GROUP PLC (GB) 1992-12-30 EP disclosed
US-5021445-A Hyperglycemic and hypertensive agents; anticoagulants, alpha2-adrenoceptor antagonists BEECHAM GROUP P.L.C. (GB) 1991-06-04 US disclosed
EP-0313288-A1 Imidazole derivatives, process for their preparation and their use as alpha 2-adreno-receptor antagonists BEECHAM GROUP PLC (GB) 1989-04-26 EP disclosed